ENDPOINTS

Exclusive: CinDome gets another $40M to advance gastroparesis drug

CinDome Pharma collected an additional $40 million from existing investors to run another Phase 2 study of its gastroparesis drug, CinRx CEO Jon Isaacsohn exclusively told Endpoints News. It's been about a year since CinDome ...

Jun 4, 2025 - 12:04
 0
Exclusive: CinDome gets another $40M to advance gastroparesis drug
CinDome Pharma collected an additional $40 million from existing investors to run another Phase 2 study of its gastroparesis drug, CinRx CEO Jon Isaacsohn exclusively told Endpoints News. It's been about a year since CinDome ...
Read More

Tags:

Previous Article

This $65 Costco Gold Star Membership comes with a $20 Digital Costco Shop Card*

Next Article

Sionna chooses Phase 2a cystic fibrosis drug after healthy volunteer study

Related Posts

Apnimed posts first set of Phase 3 sleep apnea results, aims for approval filing in 2026

Apnimed posts first set of Phase 3 sleep apnea results,...

May 19, 2025  0

Taysha’s pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff

Taysha’s pivotal trial plans; Keros to stop work on PAH...

May 29, 2025  0

RFK Jr. spars with senators over HHS budget and research cuts

RFK Jr. spars with senators over HHS budget and researc...

May 20, 2025  0